ANTIBODY-LEVEL BASED ANALYSIS OF COVID-19 CONVALESCENT SERUM (ABACCuS)

Stopped The EUA for CCP was updated by FDA, stipulating that only high titer units be used. This study required untitered units. The study became infeasible

Conditions

• COVID-19
• Severe Acute Respiratory Syndrome (SARS)
• Coronavirus Infections

Interventions

• BIOLOGICAL: COVID-19 convalescent plasma

Sponsor

Corewell Health East